A recent study led by researchers at Keck Medicine of USC reveals that episodic heavy drinking, defined as consuming four or more drinks in a day for women and five or more for men at least once a month, significantly increases the risk of advanced liver fibrosis in individuals with metabolic dysfunction–associated steatotic liver disease (MASLD). This condition affects approximately one in three adults in the U.S. and is characterized by liver fat accumulation linked to metabolic disorders. The findings indicate that those who engage in such drinking patterns are nearly three times more likely to develop serious liver scarring compared to those who consume the same total amount of alcohol more evenly over time.

The implications of these findings are profound, particularly in the context of rising rates of MASLD and alcohol-related liver disease, which have more than doubled in the last two decades. The study utilized data from over 8,000 adults collected in the National Health and Nutrition Examination Survey, highlighting the need to reconsider how alcohol consumption is assessed in clinical settings. Traditional approaches often focus solely on total alcohol intake rather than drinking patterns, which may overlook critical risks associated with episodic heavy drinking.

This research underscores the necessity for a paradigm shift in both clinical practice and public health messaging regarding alcohol consumption. It suggests that even moderate drinkers should be cautious about binge drinking, as it poses significant risks for liver health, particularly for those with pre-existing metabolic conditions. The findings call for increased awareness and preventive strategies among healthcare professionals and researchers to mitigate the growing burden of liver disease associated with episodic heavy drinking.

Source: sciencedaily.com